Silo Pharma, Inc. (NASDAQ: SILO) has announced its inaugural purchase of ResearchCoin (RSC) tokens, marking a strategic move in its digital asset treasury management. The acquisition aligns with Silo Pharma's aim to leverage multichain opportunities for long-term value. ResearchCoin is the native token of ResearchHub, a decentralized scientific collaboration platform co-founded by Coinbase CEO Brian Armstrong. CEO Eric Wesblom emphasized that this investment underscores Silo Pharma's commitment to the decentralized science (DeSci) movement and its dedication to fostering blockchain-driven innovation in biomedical research. This move highlights the company's strategic focus on integrating digital assets into its broader business model.